海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
- Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma
- Belgium, Italy, Spain, Ukraine, United Kingdom, United States
- 2011-01-05
Not recruiting
- Second Line Chemotherapy for Advanced Pancreatic Cancer
- Pancreatic Adenocarcinoma
- Italy
- 2010-09-07
Not Recruiting
- A SECOND-LINE, SINGLE ARM, PHASE II CLINICAL STUDY WITH TREMELIMUMAB, A FULLY HUMANIZED ANTI-CTLA-4 MONOCLONAL ANTIBODY, AS MONOTHERAPY IN PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA - MESOT-TREM-2008
- PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA MedDRA version: 9.1 Level: LLT Classification code 10059518 Term: Pleural mesothelioma malignant
- Italy
- 2008-09-15
Not Recruiting
- First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. An Expanded Access Program. - First BEAT
- Metastatic cancer of the colon or rectum.
- Hungary, Italy, Slovakia, Spain
- 2004-10-06
Not Recruiting
- Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients
- Estrogen receptor positive metastatic breast cancer patients;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
- Netherlands
- 2013-11-22
Not recruiting
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs
- Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues
- Spain
- 2013-11-15
Not recruiting
- MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma
- Lymphoma, Non Hodgkin
- Spain
- 2013-11-08
Not recruiting
- Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer
- Metastatic Breast Cancer
- Greece
- 2013-11-03
Not recruiting
- Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer
- Ovarian Cancer;Ovarian Cancer;Ovarian Cancer;Ovarian Cancer
- Greece
- 2013-11-03
Not recruiting
- Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer
- Early Stage Breast Carcinoma
- France
- 2013-10-25
Not recruiting
- Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction
- Multiple Myeloma
- France
- 2013-10-16
Not recruiting
- Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
- Hemochromatosis, Type 4;Ferroportin Disease;Dysmetabolic Hepatosiderosis;Diagnosis
- France
- 2013-09-20
Not Recruiting
- OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin
- - MedDRA version: 14.1 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2013-09-05
Not Recruiting
- Efficacy of ABI-007 plus Gemcitabine or Simplified LV5FU2 as First-line Therapy in Patients with Metastatic Pancreatic Cancer.
- metastatic pancreatic cancer MedDRA version: 14.1 Level: LLT Classification code 10033605 Term: Pancreatic cancer metastatic System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- France
- 2013-09-02
Not recruiting
- Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment
- Non Small Cell Lung Cancer
- Greece
- 2013-08-30
Not recruiting
- Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
- Colon Cancer Liver Metastasis
- Italy
- 2013-06-26
Not recruiting
- Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer
- Kidney Cancer
- France
- 2013-06-25
Not Recruiting
- A randomised placebo controlled trial in which mirtazapine, an antidepressant, is added for patients with depression in primary care who have not responded to treatment with first-line antidepressants.
- Treatment resistant depression MedDRA version: 16.0 Level: LLT Classification code 10045543 Term: Unipolar depression System Organ Class: 100000004873 ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- United Kingdom
- 2013-06-07
Not recruiting
- A Study of Efficacy, Safety and Pharmacokinetics of BCD-100 Monotherapy as Second Line Treatment of Patients With Non-small Cell Lung Cancer
- Non Small Cell Lung Cancer Stage IIIB;Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Belarus, Russian Federation
- 2017-08-23
Not recruiting
- A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
- Multiple Myeloma
- Spain
- 2018-06-26